secwatch / observer
8-K filed December 5, 2023, 6:59 PM ET ticker ALGN CIK 0001097149
leadership confidence high sentiment neutral materiality 0.35

Align appoints Kevin Conroy (Exact Sciences CEO) and Mojdeh Poul to board, expands to 10 directors

ALIGN TECHNOLOGY INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mojdeh Poul

Director
ALGN · ALIGN TECHNOLOGY INC
Effective
2023-12-05
Filed
December 5, 2023, 6:59 PM ET
The Board of Directors (the “Board”) of Align Technology, Inc. (“Align”) appointed Kevin T. Conroy, 58, and Mojdeh Poul, 60, to its Board, effective December 5, 2023.
Appointed

Kevin T. Conroy

Director
ALGN · ALIGN TECHNOLOGY INC
Effective
2023-12-05
Filed
December 5, 2023, 6:59 PM ET
The Board of Directors (the “Board”) of Align Technology, Inc. (“Align”) appointed Kevin T. Conroy, 58, and Mojdeh Poul, 60, to its Board, effective December 5, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mojdeh Poul was appointed as Director at ALIGN TECHNOLOGY INC.

Action
appointed
Role
Director
Exact text from the filing
The Board of Directors (the “Board”) of Align Technology, Inc. (“Align”) appointed Kevin T. Conroy, 58, and Mojdeh Poul, 60, to its Board, effective December 5, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kevin T. Conroy was appointed as Director at ALIGN TECHNOLOGY INC.

Action
appointed
Role
Director
Exact text from the filing
The Board of Directors (the “Board”) of Align Technology, Inc. (“Align”) appointed Kevin T. Conroy, 58, and Mojdeh Poul, 60, to its Board, effective December 5, 2023.
View on SEC.gov

ALIGN TECHNOLOGY INC filing history →

Source: SEC EDGAR
accession 0001097149-23-000091
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.